Skip navigation

 Login or Register | Member Centre

Posted on 12/12/02

Biovail takes stake in generic Prilosec heartburn drug

BIOTECHNOLOGY REPORTER

Biovail Corp. has taken a stake in the new generic version of heartburn blockbuster Prilosec as part of a $190-million (U.S.) acquisition of the closely held Pharma Pass group of companies.

The full text of this article has 506 words.

To continue reading this article, you will need to purchase this article.

Already have a member account? Login now

Pay-Per-View Offers To read the complete article, select one of the following options

Purchasing from globeandmail.com is quick and secure.

Single Article: $4.95

4-pack: $17.95

Back to top